AMGEN INC's Net Worth
$38.8 Billion
Who is AMGEN INC?
AMGEN INC has an estimated net worth of $38.8 Billion. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., BeiGene, Ltd., Kezar Life Sciences, Inc., Unilife Corp, TETRALOGIC PHARMACEUTICALS Corp, Epizyme, Inc., MICROMET, INC., TULARIK INC, and Neumora Therapeutics, Inc..
SEC CIK
AMGEN INC's CIK is 0000318154
Past Insider Trading and Trends
2020 was AMGEN INC's most active year for acquiring shares with 11 total transactions. AMGEN INC's most active month to acquire stocks was the month of November. 2013 was AMGEN INC's most active year for disposing of shares, totalling 6 transactions. AMGEN INC's most active month to dispose stocks was the month of November. 2020 saw AMGEN INC paying a total of $568,202,059.07 for 30,220,040 shares, this is the most they've acquired in one year. In 2023 AMGEN INC cashed out on 33,603,948 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vigil Neuroscience, Inc. (VIGL) Snapshot price: $2.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.21M |
—
|
—
| 3.21M |
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BeiGene, Ltd. (BGNE) Snapshot price: $153.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.88% | 165.53K |
$302.06 | $49,999,938.03 | 18.94M |
Sep 10
| |||
Form 4
| +0.14% | 25.76K |
$260.95 | $6,722,503.73 | 18.78M |
Scheduled
|
Dec 18
| ||
Form 4
| +1.23% | 228.14K |
$249.61 | $56,945,685.69 | 18.75M |
Scheduled
|
Dec 15 - Dec 17
| ||
Form 4
| +0.32% | 59.39K |
$248.49 | $14,757,577.60 | 18.52M |
Scheduled
|
Aug 25
| ||
Form 4
| +0.67% | 123.57K |
$234.47 | $28,971,917.93 | 18.46M |
Scheduled
|
Aug 21 - Aug 24
| ||
Form 4
| +0.93% | 168.35K |
$233.81 | $39,361,622.88 | 18.34M |
Scheduled
|
Aug 18 - Aug 20
| ||
Form 4
| +14.33% | 29.61M |
$14.23 | $421,442,751.23 | 236.25M |
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kezar Life Sciences, Inc. (KZR) Snapshot price: $0.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.12M |
—
|
—
| 1.12M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Unilife Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TETRALOGIC PHARMACEUTICALS Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 990.17K |
$7.00 | $1,912,298.91 | 990.17K |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||